With your support, we have been able to fund outstanding research, leading toward cures and improved quality of life for children with cancer. Browse through more than 1,000 funded projects below.
Use the search tool to refine your results. You can also click on a heading to sort by project title, institution name, or year the grant was awarded. Click on the project title to read more information.
You can learn about ALSF's grant review process here.
ALSF Funded Research Projects
|Project Title||Institution / Principal Investigator(s)||Grant Type||Year||State|
|Engager T cells for the Adoptive Immunotherapy of Pediatric Malignancies||Baylor College of Medicine / Stephen Gottschalk, MD||Innovation Grants||2013||Texas|
|Inflammatory Signaling in the Tumor Microenvironment||St. Jude Children's Research Hospital / Peter J. Murray, PhD||Springboard Grants||2013||Tennessee|
|Genetic Profiling and Experimental Modeling of High-risk Acute Lymphoblastic Leukemia||St. Jude Children's Research Hospital / Kathryn Roberts, PhD||Young Investigator Grants||2013||Tennessee|
|Novel Targeted Therapies for Rhabdomyosarcoma||St. Jude Children's Research Hospital / Michael Dyer, PhD||Innovation Grants||2013||Tennessee|
|Evaluation of the Literacy Demand and Racial/Ethnic Influences for Self-Reported Symptomatic Adverse Events during Childhood Cancer Therapy||Palmetto Health / Janice Withycombe, PhD||Nurse Researcher Grants||2013||South Carolina|
|DICER1, MicroRNAs and Pediatric Cancer: An Emerging Story||Research Institute of the McGill University Health Centre / William Foulkes, MD, PhD||Innovation Grants||2013||Quebec|
|Children's Hospital of Pittsburgh of UPMC Phase 1-2 Infrastructure Support Grant||University of Pittsburgh / Jean Tersak, MD||Phase I/II Infrastructure Grants||2013||Pennsylvania|
|Preclinical Development of Targeted Therapy for Neuroblastoma with ALK and CDK4/6 Dual Pathway Inhibition||Children's Hospital of Philadelphia / Yael Mossé, MD||Reach Grants||2013||Pennsylvania|
|Clinical Epidemiology Studies in Children's Oncology Group Clinical Trials||Children's Hospital of Philadelphia / Richard Aplenc, MD, PhD, MSCE||Epidemiology Grants||2013||Pennsylvania|
|Nanoparticle Delivery of Therapeutic Agents in Neuroblastomas||Children's Hospital of Philadelphia / Garrett M. Brodeur, MD||Innovation Grants||2013||Pennsylvania|